IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q3 2015 Holdings

Filed 2015-11-16 | 19 holdings | $1.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$792.0K135,80077.1%
Medivation, Inc.COM58501N101$186.9K4,397,83818.2%
Ampio Pharmaceuticals Inc.COM03209T109$9.8K3,388,3221.0%
Synthetic Biologics Inc.COM87164U102$8.5K3,734,1490.8%
Alcobra LtdSHSM2239P109$6.7K1,115,3150.7%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$5.5K1,359,7670.5%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$4.3K2,750,0000.4%
Newlink Genetics CorpCOM651511107$3.7K102,4370.4%
Advaxis Inc.COM NEW7624208$2.8K275,0000.3%
Bio Blast Pharma LtdSHSM20156101$1.7K338,1100.2%
Caladrius Biosciences IncCOM128058104$1.5K1,000,0000.1%
Advaxis Inc.W EXP 07/15/2017624117$731112,5000.1%
Keryx Biopharmaceuticals Inc.COM492515101$704200,0000.1%
OHR Pharmaceutical IncCOM NEW67778H200$566205,0000.1%
Lion Biotechnologies IncCOM53619R102$55997,1000.1%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$48365,0000.0%
Evoke Pharma IncCOM30049G104$16255,6600.0%
Zosano Pharma CorpCOM98979H103$7418,6000.0%
Aptose Biosciences IncCOM NEW03835T200$5111,9330.0%